Anti-coronavirus obtained with double-filtration plasmapheresis (DFPP) from convalescent patients

Pneumonia, Viral

Corona Virus Infection

Antibodies obtained from consenting convalescent donors will be administered to ten consecutive patients who fulfill the inclusion criteria .

Anti-coronavirus antibodies (immunoglobulins) obtained with DFPP form convalescent patients

ASST - Papa Giovanni XXIII - Unit of Nephrology

Asst Hpg23 - Eas

ASST HPG23 - Intensive Care Unit

ASST HPG23 - Microbioly and Virology Unit

Sst Hpg23 - S.I.M.T.

IRFMN - Clinical Research Center for Rare Diseases

Convalescent Antibodies Infusion in COVID 19 Patients

A Pilot Study to Explore the Efficacy and Safety of Rescue Therapy With Antibodies From Convalescent Patients Obtained With Double-filtration Plasmapheresis (DFPP) and Infused in Patients With Coronavirus Disease 2019 (COVID-19) and Need of Oxygen Support Without Mechanical Ventilation

Marker of complement activation in plasma.

Piero Luigi Ruggenenti

Director, Unit of Nephrology

Aferetica

additional aerobic training by a stepper : 35 minutes/session, 5 sessions/week and 4-5 weeks

Usual rehabilitation, without additional aerobic training

Ischemic Stroke

Aerobic training by a stepper: 35 minutes/session, 5 sessions/week and 4-5 weeks in total

Aerobic training by a stepper

Shu-Chun Huang

Stepper Aerobic Training on Fitness, Disability, Inflammation and Thrombosis in Stroke Patients

Efficacy of Stepper Aerobic Training on Cardiopulmonary Fitness, Disability, Systemic Inflammation and Thrombosis in Stroke Patients With Hemiplegia

detection of monocytes and platelets aggregation

detection the amount and time of thrombin generation.

Chang Gung Memorial Hospital

1x periradicular therapy in one intervertebral space, corresponding with pain radiating dermatome

2x periradicular therapy in two intervertebral spaces, the first corresponding with pain radiating dermatome the second according magnetic resonance visualization where stenosis is situated

Lumbar Spinal Stenosis

RTG controlled periradicular therapy (PRT) is a microinvasive interventional pain release procedure. Advantage of targeted pain therapy is exact administration of effective drugs to the nerve root in the area of the thoracic, lumbar or sacral spines.

periradicular therapy (PRT)

Algesiology ambulance

Czech republic

EuroPainClinics® Study I (Prospective Trial)

EuroPainClinics® Study I (Prospective Randomized Double Blinded Trial)

All acquired information will be noted in to the special anonymous protocol

Europainclinics z.ú.

Ranibizumab patients will receive three monthly Ranibizumab 0.5 mg/0.05 mL injections, followed by PRN dosing, as treatment for acute pseudophakic cystoid macular edema.

Triamcinolone acetonide patients will receive PRN Triamcinolone acetonide 4 mg/0.1 mL injections, every 3 months, as treatment for acute pseudophakic cystoid macular edema.

CYSTOID MACULAR EDEMA

Intravitreal injection of Ranibizumab as treatment for acute pseudophakic cystoid macular edema. Ranibizumab patients will receive three monthly Ranibizumab 0.5 mg/0.05 mL injections, followed by PRN dosing, as treatment for acute pseudophakic cystoid macular edema.

Ranibizumab,

Intravitreal injection of Triamcinolone acetonide as treatment for acute pseudophakic cystoid macular edema. Triamcinolone acetonide patients will receive PRN Triamcinolone acetonide 4 mg/0.1 mL injections, every 3 months, as treatment for acute pseudophakic cystoid macular edema.

Triamcinolone acetonide

Soll Eye

Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide

To assess the safety of intravitreal R and T for the treatment of acute pseudophakic cystoid macular edema by evaluating:
Incidence and severity of ocular adverse events, as identified by eye examination
Incidence and severity of other adverse events, as identified by physical examination, subject reporting, and changes in vital signs

Mean change in spectral domain OCT CMT from baseline (microns)

Mean change in ETDRS letters from baseline (letters)

Proportion of patients with 3 line or better ETDRS letter improvement (%)

Time to 3 line ETDRS letter improvement (days)

Genentech, Inc.

Cerebrotendinous Xanthomatosis (CTX)

Blood tests

The Bert W. Strassburger Lipid Center

Evaluation of Carotid IMT and Atherogenic Risk Factors in Patients With Cerebrotendinous Xanthomatosis

The predisposition of the serum of CTX patients to be pro-atherogenic will be evaluated by detailed lipid and lipoproteins plasma profiles, and blood chemical assessment of specific inflammatory pro-atherogenenic features.
IMT Presence of preclinical atherosclerosis will be determined by Carotid artery Intima-media thickness as a marker of risk for cardiovascular disease.

phospholipase/atrofi

Convalescent Antibodies Infusion in COVID 19 Patients

Stepper Aerobic Training on Fitness, Disability, Inflammation and Thrombosis in Stroke Patients

EuroPainClinics® Study I (Prospective Trial)

Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide

Evaluation of Carotid IMT and Atherogenic Risk Factors in Patients With Cerebrotendinous Xanthomatosis

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen